# SinoVision Technologies (Beijing)  Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/sinovision-technologies-beijing-co

- Industry: Medical Devices & Equipment
- Headquarters: Beijing, China
- Website: www.sinovision-tech.com
- Total disclosed funding: $62M
- Latest round: Series D (Dec 30, 2020)
- Investors on record: 6

## About

Based in Beijing, China and founded in 2012, SinoVision Technologies (Beijing) Co., Ltd. provides diagnostic equipment and healthcare IT solutions for the medical devices and equipment industry. The company specializes in CT scanning systems and medical imaging big data platforms designed to optimize medical resource allocation and assist with hierarchical diagnosis. The company is recognized as a "National High-Tech Enterprise". In March 2026, the firm raised CNY 50 million in pre-IPO++ funding, and in June 2026, the company began trading on the National Equities Exchange and Quotations (NEEQ) under the ticker “875199”.

The company provides X-ray medical imaging devices and integrated solutions. Specific products include X-ray computed tomography (CT) equipment, medical image processing systems, and after-sales spare parts. Additionally, the company provides medical imaging big data cloud platforms and remote diagnostic technology to support intelligent and networked healthcare services.

The company generates revenue from B2B contracts through the sale of medical equipment and customized imaging solutions, which often incorporate maintenance, support services, and spare parts.

## Funding rounds

- Series D, Dec 30, 2020, $31M — Shenzhen Capital Real Estate Fund, Longtou Capital
- Series B, Sep 4, 2017, $31M — Qiming Venture Partners, Huagai Capital, Yili Fuyi Daohe
- Series A, Nov 17, 2015 — CD Capital
- Series A, May 6, 2015 — CD Capital

## Investors

- CD Capital — Series A
- Qiming Venture Partners (https://capitalatlas.ai/funds/qiming-venture-partners) — Series B
- Huagai Capital (https://capitalatlas.ai/funds/huagai-capital) — Series B
- Yili Fuyi Daohe — Series B
- Shenzhen Capital Real Estate Fund (https://capitalatlas.ai/funds/shenzhen-capital-real-estate-fund) — Series D
- Longtou Capital (https://capitalatlas.ai/funds/longtou-capital) — Series D